Background
Transcatheter delivery of thrombolytic therapy is an effective tool in the treatment of acute deep venous thrombosis (DVT). We sought to determine an effective and safe thrombolytic regimen with tPA in the treatment of severe DVT when used in conjunction with percutaneous endovenous intervention (PEVI).
Methods
Eighty consecutive patients with acute symptomatic DVT were randomized to receive four different doses of tPA. They had all undergone PEVI from 0.5 to 18 h following presentation to the hospital. PEVI consisted of any or a combination of the following: Trellis, Angiojet, or manual suction thrombectomy, balloon venoplasty, or stenting. Following initial PEVI, if >50% thrombus remained, tPA was given via an infusion catheter for 16–20 h. Patients were randomized to receive tPA at 0.5, 1, 2, or 4 mg/h and were assigned to Groups I–IV, respectively, with 20 in each group. Warfarin was continued, and during tPA administration heparin dose was reduced to 12 U/kg per hour. The end points evaluated were venous patency post-tPA (<5% residual thrombus), bleeding, and length of hospital stay.
Methods
Eighty consecutive patients with acute symptomatic DVT were randomized to receive four different doses of tPA. They had all undergone PEVI from 0.5 to 18 h following presentation to the hospital. PEVI consisted of any or a combination of the following: Trellis, Angiojet, or manual suction thrombectomy, balloon venoplasty, or stenting. Following initial PEVI, if >50% thrombus remained, tPA was given via an infusion catheter for 16–20 h. Patients were randomized to receive tPA at 0.5, 1, 2, or 4 mg/h and were assigned to Groups I–IV, respectively, with 20 in each group. Warfarin was continued, and during tPA administration heparin dose was reduced to 12 U/kg per hour. The end points evaluated were venous patency post-tPA (<5% residual thrombus), bleeding, and length of hospital stay.
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
